In vivo effects of the synalbumin insulin antagonist.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D001681:Biological Assay; D002247:Carbon Isotopes; D003920:Diabetes Mellitus / Q000097:blood; D003964:Diaphragm / Q000378:metabolism; D004822:Epididymis / Q000378:metabolism; D006003:Glycogen / Q000032:analysis; D006801:Humans; D007275:Injections, Intravenous; D007329:Insulin Antagonists; D008297:Male; D009132:Muscles / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D012709:Serum Albumin / Q000494:pharmacology*
D002247:Carbon Isotopes; D007329:Insulin Antagonists; D012709:Serum Albumin; D006003:Glycogen
Diabetes. 1964 May-Jun;13:241-6
14166673
J Lab Clin Med. 1957 Nov;50(5):728-32
13476029
Lancet. 1954 Jan 9;266(6802):68-70
13118724
J Clin Invest. 1965 May;44:870-82
14276144
Diabetes. 1967 Jun;16(6):386-94
6025265
Lancet. 1958 Aug 16;2(7042):336-8
13576797
Diabetes. 1966 Mar;15(3):149-59
5909494
Lancet. 1961 Apr 15;1(7181):802-4
13763876
J Clin Endocrinol Metab. 1966 Mar;26(3):340-51
5908292
Metabolism. 1964 Jul;13:609-19
14192611
Diabetes. 1966 Jun;15(6):400-5
5937209
Clin Chem. 1966 Apr;12(4):194-205
4952428
Acta Physiol Scand. 1966 Mar;66(3):300-6
5917806
Acta Physiol Scand. 1964 Aug;61:314-22
14209250
Lancet. 1967 Jul 1;2(7505):21-2
4165440
Diabetes. 1965 Jan;14:19-26
14260095